Core Viewpoint - The Shanghai Stock Exchange issued a regulatory warning to Shenzhen Yahui Long Biotechnology Co., Ltd. for inaccurate and incomplete information disclosure regarding its strategic cooperation with Shenzhen Brain Machine Star Chain Technology Co., Ltd. [1][2] Group 1: Regulatory Actions - The Shanghai Stock Exchange found that Yahui Long's announcement about its cooperation with Brain Machine Star Chain contained inconsistent statements regarding the technology paths, particularly concerning invasive techniques [2][3] - The company and its then Secretary of the Board, Wang Mingyang, were held responsible for failing to ensure accurate and complete information disclosure, violating multiple rules of the Shanghai Stock Exchange [2][3] Group 2: Company Background and Financials - Yahui Long was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on May 17, 2021, with an initial public offering price of 14.80 yuan per share, raising a total of 606.8 million yuan [6] - The company aimed to use the raised funds for upgrading its R&D center, expanding production capacity, and enhancing its marketing system, among other projects [6]
亚辉龙被监管警示 此前一个季度实控人套现8445.7万元